A self-controlled, cross-over study of intensive insulin treatment with needle-based injection versus needle-free injection in hospitalized patients with type 2 diabetes.

Quanying Wu, Mingqun Deng, Weihao Wang, Shuyi Yu, Miao Wang, Chao Sun, Qi Pan, Lixin Guo
Author Information
  1. Quanying Wu: Nursing Department, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  2. Mingqun Deng: Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  3. Weihao Wang: Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  4. Shuyi Yu: Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  5. Miao Wang: Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  6. Chao Sun: Nursing Department, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  7. Qi Pan: Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.
  8. Lixin Guo: Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China.

Abstract

Background and Aims: Needle injection and needle-free injection were proven effective in improving glycated hemoglobin (HbA1c) in type 2 diabetes mellitus (T2DM) patients. However, it is unclear if needle-free and needle injections of insulin during intensive insulin therapy in hospitalized patients provide similar efficacy and safety benefits.
Methods: A self-controlled cross-over study was conducted on 62 patients with T2DM who received intensive long-acting and short-acting insulin injections with or without needles. The 7-point blood glucose test was performed on the 6th day after insulin administration and the injection method switched on the 7th day of hospitalization. The difference was compared in 7-point blood glucose levels.
Results: The blood glucose levels at fasting (mean difference=-1.09 ± 2.38mmol/L, 95% CI, -1.69 to -0.48, p=0.0007) and post-breakfast (-1.14 ± 3.02mmol/L, 95%CI, -1.91 to -0.37, p=0.004) were better when patients were receiving needle-free injections compared to when receiving a needle injection. Indeed, daily blood glucose fluctuation, which presented as the area under the curve of glycemia, was decreased in needle-free injection periods (-0.3.48 ± 9.64, 95%CI, -5.95 to -1.01, p=0.0065). There was no significant difference in the dose of long-acting insulin between the two injection methods (-0.32 ± 2.69, 95%CI, -0.99 to 0.37, p>0.05). The dose of fast-acting insulin during the needle-free period was lower than that of when patients received needle injections (-1.66 ± 6.45, 95%CI, -3.29 to -0.025, p<0.05). There was no significant difference in satisfaction between the two regimens (-0.59 ± 1.55,95%CI, -0.938 to 0.509, p=0.557), but there was a significant difference in pain experience, favoring needle-free injections (p < 0.001).
Conclusion: Glycemia was better controlled by needle-free insulin injections in hospitalized T2DM patients subjected to intensive glycemic control. These patients also experienced less pain than when insulin was injected with a needle.

Keywords

References

  1. Expert Opin Drug Deliv. 2019 Sep;16(9):995-1002 [PMID: 31359813]
  2. Am J Med. 2013 Oct;126(10):925.e11-22 [PMID: 23810406]
  3. Diabetes Res Clin Pract. 2017 Apr;126:248-253 [PMID: 28288434]
  4. Expert Opin Pharmacother. 2017 Feb;18(3):233-234 [PMID: 28067057]
  5. Expert Opin Drug Deliv. 2016 Sep;13(9):1203-7 [PMID: 27267431]
  6. Curr Med Res Opin. 2014 Jun;30(6):1087-93 [PMID: 24552616]
  7. Medicine (Baltimore). 2017 Jan;96(1):e5482 [PMID: 28072690]
  8. Int J Clin Pract. 2015 Oct;69(10):1050-70 [PMID: 26147376]
  9. Diabet Med. 2022 Jan;39(1):e14672 [PMID: 34407260]
  10. Diabetes Care. 2011 Aug;34(8):1804-8 [PMID: 21715522]
  11. EClinicalMedicine. 2020 Jun 04;23:100368 [PMID: 32529176]
  12. Mayo Clin Proc. 2016 Sep;91(9):1224-30 [PMID: 27594186]
  13. Diabetes Technol Ther. 2017 Nov;19(11):623-632 [PMID: 29058477]
  14. Diabetes Ther. 2021 May;12(5):1379-1398 [PMID: 33738775]

MeSH Term

Humans
Diabetes Mellitus, Type 2
Hypoglycemic Agents
Cross-Over Studies
Blood Glucose
Insulin

Chemicals

Hypoglycemic Agents
Blood Glucose
Insulin

Word Cloud

Created with Highcharts 10.0.0insulininjectionneedle-freepatients-0injections±intensive-195%CI2needlebloodglucosedifferencep=0diabetesT2DMhospitalizedcross-overstudysignificant0typetherapyself-controlledreceivedlong-acting7-pointdaycomparedlevels6948337betterreceivingdosetwo05painBackgroundAims:NeedleproveneffectiveimprovingglycatedhemoglobinHbA1cmellitusHoweverunclearprovidesimilarefficacysafetybenefitsMethods:conducted62short-actingwithoutneedlestestperformed6thadministrationmethodswitched7thhospitalizationResults:fastingmeandifference=-10938mmol/L95%CI0007post-breakfast1402mmol/L91004Indeeddailyfluctuationpresentedareacurveglycemiadecreasedperiods964-595010065methods3299p>0fast-actingperiodlower66645-329025p<0satisfactionregimens59155938509557experiencefavoringp<001Conclusion:Glycemiacontrolledsubjectedglycemiccontrolalsoexperiencedlessinjectedtreatmentneedle-basedversushospital

Similar Articles

Cited By